{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:52:47Z","timestamp":1784843567854,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":3,"publisher":"Springer US","isbn-type":[{"value":"9781071637852","type":"print"},{"value":"9781071637869","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3786-9_8","type":"book-chapter","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:03:05Z","timestamp":1710950585000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Static Headspace Gas Chromatography Method for Quantitation of Residual Solvents in Nanoformulations"],"prefix":"10.1007","author":[{"given":"Krishna","family":"Kattel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Clogston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"3","key":"8_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0939-6411(96)00037-9","volume":"43","author":"C Witschi","year":"1997","unstructured":"Witschi C, Doelker E (1997) Residual solvents in pharmaceutical products: acceptable limits, influences on physicochemical properties, analytical methods and documented values. Eur J Pharm Biopharm 43(3):215\u2013242","journal-title":"Eur J Pharm Biopharm"},{"key":"8_CR2","unstructured":"<467> Residual solvents. United States Pharmacopeia-National Formulary. https:\/\/www.uspnf.com\/sites\/default\/files\/usp_pdf\/EN\/USPNF\/generalChapter467Current.pdf. Accessed 19 July 2023"},{"key":"8_CR3","unstructured":"Impurities: Guideline for Residual Solvents, Q3C(R8). International Council for Harmonisation of Technical Requirements for Pharmacueticals for Human Use. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q3C-R8_Guideline_Step4_2021_0422_1.pdf. Accessed 19 July 2023"}],"container-title":["Methods in Molecular Biology","Characterization of Nanoparticles Intended for Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3786-9_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:03:37Z","timestamp":1710950617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3786-9_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637852","9781071637869"],"references-count":3,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3786-9_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"21 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}